This announcement is a separate document:
迪哲医药：北京市中伦律师事务所关于迪哲（江苏）医药股份有限公司2022年限制性股票激励计划预留授予相关事项的法律意见书
Dizhe Pharmaceuticals: Legal Opinion of Beijing Zhonglun Law Firm on matters relating to the reservation grant of the 2022 Restricted Stock Incentive Plan of Dizhe (Jiangsu) Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated